Takes Two to Tango

Strategies to increase the value of the asset by pooling fragmented datasets. All editions by Akash M L Mathur. Published biweekly, 45 editions so far.

Edition 01

Turning HealthTech into Health Impact

Edition 02

Healthtech / Medtech Success

Edition 03

The Health Stack and the Story-Market Fit

Edition 04

"It Understands Medicine, not Just English"

Edition 05

How Founders Could have Protected Equity - Rise and Stall of a Path AI

Edition 06

Unlocking Global Markets Playbook!

Edition 07

Example of Mature AI Application to Healthtech

Edition 08

"People don't want medicines. They just want to be healthy."

Edition 09

Same Tech Stack. Different Applications. Different TAM. Different Valuations

Edition 10

Wellness at Work - a Collective Conversation

Edition 11

When Leaders Speak, Solutions Emerge - Naturally

Edition 12

Contributing to Meeting Global Objectives of Ortho, Physio and Sports Training

Edition 13

Knowledge Based GTM — One Collaboration at a Time

Edition 14

Knowledge - the Fifth Dimension in Healthtech GTM

Edition 15

Spray and Pray or Seed and Harvest - Healthtech Dilemma

Edition 16

The Market is Always Talking - Are you Listening?

Edition 17

The First 50 Champions - Momentum ahead of the Product

Edition 18

The Market Spoke. Now It Wants Proof

Edition 19

Before the Survey, Much Before the Pilot..

Edition 20

Sooooooo high valuation with no sales??

Edition 21

They Didn't Lose in Court. They Ran Out of Time.

Edition 22

How Investors View Patents - Insurance, not Intellect

Edition 23

What We Learned Evaluating 27 HealthTech Companies in 2025

Edition 24

Lessons from the 24 Companies we did not carry for US GTM in 2025

Edition 25

The Top 5 Reasons HealthTech Patents End Up in Court

Edition 26

USFDA's 2026 Update — What It Means for Your Product

Edition 27

Credibility Gets the Valuations and Funding

Edition 28

Why Your Deck is Getting Ghosted

Edition 29

Why Investors Ghost Before They Open Your Deck

Edition 30

How to Use High Value Logos and Advisors

Edition 31

Why We backed one (Even Though we agree Founders carry a Company)

Edition 32

Stealth Mode Bet: Why We Backed a Mental Wellbeing Startup

Edition 33

AmethIntel — System to look at Multiple Angles and Establish Data Backed Valuation

Edition 34

A Tale of Two Business Plans: Data Investors Will Make Mandatory for Every Pitch Deck

Edition 35

Uncut Diamonds and What A Directed IP Search can Identify

Edition 36

The Data That Connected Ten Years Too Late — Why we Created AmethIntel and the CEACAM5 Case Study

Edition 37

Simultaneous, Iterative Optimization Methodology

Edition 38

New Developments in CEACAM5 — EMD, Atari, 11 others. Forty-Four Competitors, and Counting

Edition 39

Can You Design a Clinical Trial Today to Decide Who Leads Ten Years from Now?

Edition 40

You Have the Valuation. Do You Have the Assumptions Behind It?

Edition 41

Everyone who needs it won't pay for it.

Edition 42

It Takes Two to Build a Business

Edition 43

What are the assumptions of the Company, and how do they show up?

Edition 44

The Science, The Investment Case, and The Bridge

Edition 45

Your Product Can Serve Three Markets. Your Plan Names One.